Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.
Leon Alexander Mclaren BergeBettina Kulle AndreassenJo Steinson StenehjemTrond HeirØystein KarlstadAsta JuzenieneReza GhiasvandInger Kristin LarsenAdéle C GreenMarit Bragelien VeierødTrude Eid RobsahmPublished in: Clinical epidemiology (2020)
We found a positive association between use of immunosuppressants and melanoma risk, with the highest risk seen for drugs prescribed to OTRs. Knowledge about this risk increase is important for physicians and users of these drugs, for intensified surveillance, awareness and cautious sun exposure.